IP Library › Assignment 033087/0015
Patent Assignment
Reel/Frame 033087/0015

Corrective Assignment to Correct the Assignor Previously Recorded on Reel 032602 Frame 0053. Assignor(S) Hereby Confirms the Change of Name.

Recorded: 2014-06-05 Pages: 5
Assignor
SYNTONIX PHARMACEUTICALS, INC.
Executed: 2010-05-19
Assignee
BIOGEN IDEC HEMOPHILIA INC.
9 FOURTH AVENUE, WALTHAM, MASSACHUSETTS, 02451
Covered Property (1)
Clotting Factor-Fc Chimeric Proteins to Treat Hemophilia
Patent: 8,815,250 →
Application: 13/792,889 →
Publication: US 2013/0273047
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 28, 2013
From: RIVERA, DANIEL S.; PETERS, ROBERT T.; BITONTI, ALAN J.
To: SYNTONIX PHARMACEUTICALS, INC.
Reel/Frame 030104/0265 →
Change of Name Apr 3, 2014
From: SYNTONIX PHARMACEUTCIALS, INC.
To: BIOGEN IDEC HEMOPHILIA INC.
Reel/Frame 032602/0053 →
Change of Name Apr 30, 2015
From: BIOGEN IDEC HEMOPHILIA INC.
To: BIOGEN HEMOPHILIA INC.
Reel/Frame 035553/0325 →
Change of Address Jul 2, 2015
From: BIOGEN HEMOPHILIA INC.
To: BIOGEN HEMOPHILIA INC.
Reel/Frame 036051/0773 →
Change of Name Feb 16, 2017
From: BIOGEN HEMOPHILIA INC.
To: BIOVERATIV THERAPEUTICS INC.
Reel/Frame 041735/0662 →